|
Emerging Technology and Best Practices Seminar Series
Nanotechnology in Medicine: From Diagnostics to Therapeutics
Back to agenda
Dr. Linda K. Molnar
BIO
Dr. Linda K. Molnar is a Program Officer in the Office of the Director, National Cancer Institute (NCI). In her role, she coordinates program and research activities for the NCI Alliance in Cancer Nanotechnology, a $144M initiative. Her background includes business development and research and development roles at the NASA Ames Center for Nanotechnology, Caliper Life Sciences, and Rohm and Haas Company. She received her Ph.D. in Materials Science and Engineering from the Massachusetts Institute of Technology, her B.S. in Chemistry with Honors from the University of Pittsburgh (magna cum laude), and she has completed the Wharton Management Program. She is the holder of 10 issued patents in the nanotechnology field and has published in leading journals.
|